Generics

JERUSALEM — Teva Pharmaceutical Industries has completed its acquisition of another drug maker, following clearance from the Federal Trade Commission.

Teva said its acquisition of Frazier, Pa.-based Cephalon, valued at $6.8 billion, will help the company build out its branded and specialty pharmaceuticals business. The combined company is expected to generate about $20 billion in revenues (on a pro-forma basis) for the 12 months ended in June.

In relation to the deal, Teva sold three generic drugs to Par Pharmaceutical Cos.

PARSIPPANY, N.J. — Watson Pharmaceuticals is looking to market a generic version of a postmenopausal osteoporosis treatment.

The generic drug maker said its subsidiary, Watson Lavs, has filed an abbreviated new drug application with the Food and Drug Administration for risedronate sodium delayed-release tablets in the 35-mg. strength. The drug is a generic version of Atelvia, which is manufactured and distributed by Warner Chilcott.

CINCINNATI — Prasco Labs announced it will serve as the exclusive U.S. distributor and pharmaceutical services provider for a line of branded prescription drugs.

Prasco said that it will distribute products under the Aspen Global brand, the generic drug maker said. Aspen currently serves Africa, Latin America, Europe, Australia and Asia markets.

ZEJTUN, Malta — Generic drug maker Actavis is donating 2 million euros worth of medicines to Libya, the company said.

Actavis announced the shipment of 170 pallets of medicines from Malta to the Libyan capital of Tripoli. The goods left Malta on Sunday and are scheduled to arrive in Tripoli this week. The products include cardiology, anti-infective, pain management and gastrointestinal drugs, among others.

PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals is seeking Food and Drug Administration approval for a generic treatment for attention deficit hyperactivity disorder, the company said.

Watson announced that it filed a regulatory approval application with the FDA for methylphenidate transdermal system, a patch designed to deliver the central nervous system stimulant methylphenidate over a nine-hour period. The drug is a generic version of Noven Pharmaceuticals' Daytrana.

PHILADELPHIA — Lannett announced that it has begun shipping three generic drugs that recently were approved by the Food and Drug Administration.

The generic drug maker said that it has shipped diethylpropion tablets in the 25-mg strength; phentermine hydrochloride capsules in the 37.5-mg strength and loxapine capsules in 5-mg, 10-mg, 25-mg and 50-mg strengths.

CLEVELAND — ECRM recently was recognized for its involvement with the nonprofit organization Operation Shoebox, a charity that delivers personal care items, food and stationery to soldiers stationed all around the world.

BOSTON — More than half of parents in Massachusetts said their children have access to prescription drugs that could be abused, according to a new survey.